Identification of Spontaneous Delivery Markers (TrophY2)

December 4, 2025 updated by: Assistance Publique - Hôpitaux de Paris

Markers of Fetal Membranes Remodelling in Cervicovaginal Fluid and Delivery

The investigators project aims to identify, in pregnant women, discriminating molecules to allow an early detection of women who will spontaneously deliver prematurely, suitable in routine clinical practice.

Human parturition is tightly correlated with hormonal changes at the maternal-fetal interface during pregnancy, that may control cell interactions and fetal membranes (the water bag) remodelling. Precocious remodelling may lead to a premature onset of labor, associated or not with premature rupture of membrane whether the cause is infectious or not.

In this regard, remodelled fetal membranes overlying the cervix may discharge signals that could be detectable in cervico-vaginal fluids and serve as biomarkers of the imminence of delivery. Such information on delivery timing may be of great importance for an adequate prediction that would change drastically the management of threatening preterm delivery.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Prematurity is a major Public Health concern in developed countries, since it is the first cause of perinatal morbi-mortality and of cerebral palsy in early childhood. Premature birth rate has risen by 36 percent over the last 25 years to reach 7.2% in 2010 in France. Antenatal corticosteroids administration before 34 weeks and in utero transfer in high-qualified maternity wards are ones of the rare antenatal therapies recommended to improve neonatal complications of preterm delivery. Early identification of women with high risk of preterm birth should be helpful to implement those prophylactic measures. Moreover discriminating true preterm labor (PTL) vs. symptoms of PTL in women, who will finally deliver at term, would reduce unnecessary hospitalizations and prescriptions.

During human gestation, fetal membranes (the "water bag") encompass the amnion, facing the amniotic cavity, and the chorion, lining the maternal decidua and comprising trophoblast cells. Membranes usually remain intact until their spontaneous rupture, close to the first stage of labor at term. Often seen as a simple inert shell, with a role of "airbag" for the developing fetus, the membranes provide yet a large surface of interaction between maternal and fetal tissues and function as a transient endocrine organ with immune properties.

Specific remodelling of the membranes is observed at term prior to delivery. During this remodelling, drastic changes in extracellular matrix occur, with the secretion of specific molecules. The investigators hypothesize that premature fetal membranes remodelling occurs weeks prior to actual birth and may be able to be detected in women at risk for preterm birth, i.e. presenting signs of PTL. This study investigates if the detection of fetal membranes remodelling in cervico-vaginal fluids can accurately identify those women at greatest risk for preterm birth. A prospective cohort of pregnant women will before 32 weeks of gestation with symptoms of preterm labor be enrolled. As negative controls, healthy pregnant women at 12-15 or 35-36 weeks of gestation or non-pregnant women will be recruited. As positive controls, healthy pregnant woman at term (over 38 weeks of gestation) will be enrolled. The main outcome assessed is preterm delivery.

Study Type

Interventional

Enrollment (Actual)

238

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Paris, France, 75014
        • Maternité Port Royal-Cochin

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

- Singleton pregnancy, monitored in Port Royal or secondarily transferred, between 24 and 32 GA. Hospitalization for preterm labor (cervix < 25 mm at transvaginal cervical ultrasound) or -Singleton pregnancy, monitered in Port Royal between 15-16 weeks of gestation, without complication.

or - Singleton pregnancy, monitered in Port Royal between 35-36 weeks of gestation, without complication.

or - Healthy woman, no pregnancy.

Exclusion Criteria:

  • Minor
  • Not affiliated to health insurance
  • Persons under guardianship or judicial protection
  • Infection with HIV, Hepatitis B Virus (HBV) or Hepatitis C Virus (HCV)
  • Diabetes or chronic inflammatory disease
  • Carrier of B streptococcus
  • Cervical strapping
  • Fetus with chromosomal abnormalities
  • Infections
  • Premature rupture of membrane

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Screening
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Non pregnant women
Healthy pregnancy : women 15-16 weeks of gestation, at 35-36 weeks of gestation, and >37 weeks of gestation and planed cesarean prior labor
Sample of cervicovaginal secretions made by the surgical team using a sterile swab introduced directly into the posterior fornix of vagina for one minute during the insertion of the urinary catheter
Experimental: Preterm Labor
Pregnant women admitted for preterm labor
Sample of cervicovaginal secretions made by the surgical team using a sterile swab introduced directly into the posterior fornix of vagina for one minute during the insertion of the urinary catheter
Experimental: Healthy pregnancy
Healthy pregnancy : women 15-16 weeks of gestation, at 35-36 weeks of gestation, and >37 weeks of gestation and planed cesarean prior labor
Sample of cervicovaginal secretions made by the surgical team using a sterile swab introduced directly into the posterior fornix of vagina for one minute during the insertion of the urinary catheter

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Delivery
Time Frame: until Day 14
Assessed among patients in preterm labor between 24 - 32 GA
until Day 14

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Delivery before 34 GA
Time Frame: until Day 14
Assessed among patients in preterm labor between 24 - 32 GA
until Day 14
composite Prenatal maternal care
Time Frame: until Delivery

Assessed by :

  • number of hospitalization,
  • total duration of hospitalization for preterm labor,
  • use of tocolytic treatment, administration of prenatal corticotherapy,
  • time between the last injection of corticosteroids and birth
until Delivery
composite Neonatal outcome
Time Frame: At Birth

Assessed by :

  • birth weight,
  • Apgar score at 5 minutes,
  • arterial cord pH,
  • transfer to neonatology unit or neonatal intensive care,
  • death,
  • In case of transfer neonatal unit or neonatal intensive care : duration of hospitalization, use of respiratory assistance
At Birth
composite Obstetric outcome
Time Frame: At Delivery

Assessed by :

  • pregnancy term,
  • way to start labor (spontaneous, induction, caesarean before labor)
  • duration of labor,
  • maternal fever,
  • antibiotics during labor,
  • mode of delivery,
  • indications of cesarean
At Delivery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Celine MEHATS, PhD, INSERM U1016 - Cochin Hospital Public Hospitals of Paris

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 14, 2014

Primary Completion (Actual)

November 14, 2017

Study Completion (Actual)

April 16, 2018

Study Registration Dates

First Submitted

August 7, 2014

First Submitted That Met QC Criteria

August 25, 2014

First Posted (Estimated)

August 26, 2014

Study Record Updates

Last Update Posted (Estimated)

December 11, 2025

Last Update Submitted That Met QC Criteria

December 4, 2025

Last Verified

December 1, 2025

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Preterm Labor (24 GA - 32 GA)

Clinical Trials on Cervicovaginal swab

Subscribe